# MindWalk Holdings Corp.: overview HYFT · Nasdaq · CIK 1715925 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Apr 30 Pages: [Overview](/companies/hyft.md) · [Financials](/companies/hyft/financials.md) · [Filings](/companies/hyft/filings.md) · [Insiders](/companies/hyft/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-04-30) | FY2022 (2022-04-30) | FY2023 (2023-04-30) | FY2024 (2024-04-30) | FY2025 (2025-04-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [17.9](/filings/0001193125-22-205824.md) | [19.4](/filings/0000950170-24-087127.md) | [20.7](/filings/0000950170-25-099392.md) | [24.5](/filings/0000950170-25-099392.md) | [24.5](/filings/0000950170-25-099392.md) | | Gross margin | % | [64.4%](/filings/0001193125-22-205824.md) | [56.7%](/filings/0000950170-24-087127.md) | [56.0%](/filings/0000950170-25-099392.md) | [49.2%](/filings/0000950170-25-099392.md) | [55.3%](/filings/0000950170-25-099392.md) | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [(41.0%)](/filings/0001193125-22-205824.md) | [(86.3%)](/filings/0000950170-24-087127.md) | [(128.5%)](/filings/0000950170-25-099392.md) | [(106.5%)](/filings/0000950170-25-099392.md) | [(123.3%)](/filings/0000950170-25-099392.md) | | Diluted EPS | $ per share | not reported | [(0.85)](/filings/0000950170-24-087127.md) | [(1.07)](/filings/0000950170-25-099392.md) | [(1.02)](/filings/0000950170-25-099392.md) | [(0.91)](/filings/0000950170-25-099392.md) | | Free cash flow | $m | [(2.0)](/filings/0001193125-22-205824.md) | [(11.0)](/filings/0000950170-24-087127.md) | [(21.3)](/filings/0000950170-25-099392.md) | [(4.6)](/filings/0000950170-25-099392.md) | [(7.2)](/filings/0000950170-25-099392.md) | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hyft/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $822.8k | 520,769 | | Reduced −13,247 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $337.1k | 213,380 | | Reduced −19,100 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $244.0k | 154,411 | | New +154,411 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $214.8k | 135,967 | | Added +110,721 | | [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $123.2k | 77,947 | | Added +8,000 | | [Allianz Asset Management GmbH](/funds/1535323.md) | 2026-06-30 | $55.3k | 35,000 | | Unchanged | | [Gradient Capital Advisors, LLC](/funds/1727917.md) | 2026-06-30 | $42.0k | 26,551 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $40.3k | 25,490 | | Added +9,356 | | [Federation des caisses Desjardins du Quebec](/funds/2022297.md) | 2026-06-30 | $36.8k | 23,265 | | Unchanged | | [Tradition Wealth Management, LLC](/funds/1843010.md) | 2026-06-30 | $20.8k | 13,177 | | Unchanged | ## Recent filings [All 284 filings](/companies/hyft/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 17:08 ET | [6-K](/filings/0001193125-26-429101.md) | Report of a foreign private issuer, period 2026-10-22 | 0001193125-26-429101 | | 2026-10-21 | 08:29 ET | [6-K](/filings/0001193125-26-427256.md) | Report of a foreign private issuer, period 2026-10-21 | 0001193125-26-427256 | | 2026-10-14 | 10:28 ET | [6-K](/filings/0001193125-26-421155.md) | Report of a foreign private issuer, period 2026-10-14 | 0001193125-26-421155 | | 2026-10-06 | 10:01 ET | [6-K](/filings/0001193125-26-415053.md) | Report of a foreign private issuer, period 2026-10-06 | 0001193125-26-415053 | | 2026-10-01 | 16:05 ET | [6-K](/filings/0001193125-26-410650.md) | Report of a foreign private issuer, period 2026-10-01 | 0001193125-26-410650 | | 2026-09-21 | 16:16 ET | [6-K](/filings/0001193125-26-396682.md) | Report of a foreign private issuer, period 2026-09-21 | 0001193125-26-396682 | | 2026-09-21 | 09:48 ET | [6-K](/filings/0001193125-26-396193.md) | Report of a foreign private issuer, period 2026-09-21 | 0001193125-26-396193 | | 2026-09-14 | 16:58 ET | [6-K](/filings/0001193125-26-390719.md) | Report of a foreign private issuer, period 2026-09-14 | 0001193125-26-390719 | | 2026-09-14 | 16:57 ET | [6-K](/filings/0001193125-26-390714.md) | Report of a foreign private issuer, period 2026-07-31 | 0001193125-26-390714 | | 2026-09-14 | 09:55 ET | [6-K](/filings/0001193125-26-389966.md) | Report of a foreign private issuer, period 2026-09-14 | 0001193125-26-389966 | ## Latest annual report [Form 20-F for the fiscal year ended Apr 30, 2026](/filings/0001193125-26-312694.md), filed Jul 23, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1715925 - Tickers: HYFT - Exchange: Nasdaq - SIC code: 2834 Pharmaceutical Preparations - State of incorporation: A1 - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 10:02 ET. No prices; not investment advice.